Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer’s Disease

Inflammatory mediators are closely associated with the pathogenesis of neurodegenerative changes in Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Osteopontin (OPN) is a proinflammatory cytokine that has been shown to play an important role in various neuroinflammatory diseases. Howev...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuan Sun, Xue Song Yin, Hong Guo, Rong Kun Han, Rui Dong He, Li Jun Chi
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/615745
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556762417332224
author Yuan Sun
Xue Song Yin
Hong Guo
Rong Kun Han
Rui Dong He
Li Jun Chi
author_facet Yuan Sun
Xue Song Yin
Hong Guo
Rong Kun Han
Rui Dong He
Li Jun Chi
author_sort Yuan Sun
collection DOAJ
description Inflammatory mediators are closely associated with the pathogenesis of neurodegenerative changes in Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Osteopontin (OPN) is a proinflammatory cytokine that has been shown to play an important role in various neuroinflammatory diseases. However, the function of OPN in AD and MCI progression is not well defined. Cerebrospinal fluid (CSF) and plasma samples were obtained from 35 AD patients, 31 MCI patients, and 20 other noninflammatory neurologic diseases (OND). Concentrations of OPN in the CSF and plasma were determined by enzyme-linked immunosorbent assay. During a 3-year clinical followup, 13 MCI patients converted to AD (MCI converters), and 18 were clinically stable (MCI nonconverters). CSF OPN concentrations were significantly increased in AD and MCI converters compared to OND, and increased levels of OPN in AD were associated with MMSE score; OPN protein levels both in the CSF and plasma of newly diagnosed AD patients were higher than that of chronical patients. In MCI converters individuals tested longitudinally, both plasma and CSF OPN concentrations were significantly elevated when they received a diagnosis of AD during followup. Further wide-scale studies are necessary to confirm these results and to shed light on the etiopathogenic role of osteopontin in AD.
format Article
id doaj-art-91837e97e636423b98f87585e4f7764c
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-91837e97e636423b98f87585e4f7764c2025-02-03T05:44:30ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/615745615745Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer’s DiseaseYuan Sun0Xue Song Yin1Hong Guo2Rong Kun Han3Rui Dong He4Li Jun Chi5Department of Neurology, Bei Jing Daopei Hospital, Bei Jing 100749, ChinaDepartment of Emergency, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, ChinaDepartment of Paediatrics, Daqing Oilfied General Hospital, Daqing 163311, ChinaDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, ChinaDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, ChinaDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, ChinaInflammatory mediators are closely associated with the pathogenesis of neurodegenerative changes in Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Osteopontin (OPN) is a proinflammatory cytokine that has been shown to play an important role in various neuroinflammatory diseases. However, the function of OPN in AD and MCI progression is not well defined. Cerebrospinal fluid (CSF) and plasma samples were obtained from 35 AD patients, 31 MCI patients, and 20 other noninflammatory neurologic diseases (OND). Concentrations of OPN in the CSF and plasma were determined by enzyme-linked immunosorbent assay. During a 3-year clinical followup, 13 MCI patients converted to AD (MCI converters), and 18 were clinically stable (MCI nonconverters). CSF OPN concentrations were significantly increased in AD and MCI converters compared to OND, and increased levels of OPN in AD were associated with MMSE score; OPN protein levels both in the CSF and plasma of newly diagnosed AD patients were higher than that of chronical patients. In MCI converters individuals tested longitudinally, both plasma and CSF OPN concentrations were significantly elevated when they received a diagnosis of AD during followup. Further wide-scale studies are necessary to confirm these results and to shed light on the etiopathogenic role of osteopontin in AD.http://dx.doi.org/10.1155/2013/615745
spellingShingle Yuan Sun
Xue Song Yin
Hong Guo
Rong Kun Han
Rui Dong He
Li Jun Chi
Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer’s Disease
Mediators of Inflammation
title Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer’s Disease
title_full Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer’s Disease
title_fullStr Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer’s Disease
title_full_unstemmed Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer’s Disease
title_short Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer’s Disease
title_sort elevated osteopontin levels in mild cognitive impairment and alzheimer s disease
url http://dx.doi.org/10.1155/2013/615745
work_keys_str_mv AT yuansun elevatedosteopontinlevelsinmildcognitiveimpairmentandalzheimersdisease
AT xuesongyin elevatedosteopontinlevelsinmildcognitiveimpairmentandalzheimersdisease
AT hongguo elevatedosteopontinlevelsinmildcognitiveimpairmentandalzheimersdisease
AT rongkunhan elevatedosteopontinlevelsinmildcognitiveimpairmentandalzheimersdisease
AT ruidonghe elevatedosteopontinlevelsinmildcognitiveimpairmentandalzheimersdisease
AT lijunchi elevatedosteopontinlevelsinmildcognitiveimpairmentandalzheimersdisease